NEURACEQ: payments to doctors
Payments that named NEURACEQ as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $74K
- Providers
- 963
- Transactions
- 1,440
- Average per transaction
- $52
The per-transaction average — $52 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 963 providers the average total is $77, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Life Molecular Imaging Ltd | $68,051 | 91.4% |
| Piramal Imaging Limited | $6,377 | 8.6% |